Browsing Tag
Imviva Biotech
1 post
Orphan drug designation for CTD402 raises stakes for allogeneic CAR-T in relapsed T-cell leukemia
CTD402 secures FDA orphan designation. Read how this raises execution stakes for allogeneic CAR-T in relapsed T-cell leukemia.